The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.

导出 LinkOut

翻译打印收藏纠错

作者： Toru,Aoyama ^[1] ; Yukio,Maezawa ^[2] ; Itaru,Hashimoto ^[3] ; Kentaro,Hara ^[2] ; Ayako,Tamagawa ^[4] ; Keusike,Kazama ^[3] ; Aya,Kato ^[5] ; Haruhiko,Cho ^[3] ; Masato,Nakazono ^[3] ; Masakatsu,Numata ^[3] ; Shinnosuke,Kawahara ^[3] ; Mie,Tanabe ^[2] ; Jyunya,Morita ^[3] ; Takashi,Oshima ^[3] ; Aya,Saito ^[3] ; Norio,Yukawa ^[3] ; Yasushi,Rino ^[3]

作者单位： Department of Surgery, Yokohama City University, Yokohama, Japan; t-aoyama@lilac.plala.or.jp. ^[1] Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan. ^[2] Department of Surgery, Yokohama City University, Yokohama, Japan. ^[3] Department of Surgery, Yokohama City University, Yokohama, Japan; itarum1n1@hotmail.com. ^[4] Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. ^[5]

关键词 CALLY CRP-albumin-lymphocyte Index curative treatment gastric cancer prognostic biomarker

主题词人类(Humans);预后(Prognosis);胃肿瘤(Stomach Neoplasms);淋巴细胞(Lymphocytes);淋巴细胞计数(Lymphocyte Count);C反应蛋白质(C-Reactive Protein);回顾性研究(Retrospective Studies)

DOI 10.21873/anticanres.16961

PMID 38537973

发布时间 2024-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交